Top Story

Apellis to acquire Potentia Pharmaceuticals

November 21, 2014

Apellis Pharmaceuticals has entered into an agreement to acquire Potentia Pharmaceuticals, according to a press release.

Through the agreement, Apellis obtained the necessary intellectual property rights to develop a complement inhibitor drug compound (APL-2) for the treatment of dry age-related macular degeneration.

thumbnail for video 3903679109001 Meeting News CoverageVideo

VIDEO: Management of zonular dehiscence

November 21, 2014
NEW YORK — At OSN New York 2014, Cynthia Matossian, MD, discusses strategies for handling cases of zonular dehiscence in cataract surgery.

Imprimis reports $2.5 million net loss in third quarter

November 21, 2014
Imprimis Pharmaceuticals reported a net loss of $2.5 million, or $0.27 per common share, in the third quarter, compared with a loss of $2.1 million, or $0.23 per common…

Ocular Therapeutix to evaluate sustained-release travoprost for glaucoma, ocular hypertension

November 21, 2014
Ocular Therapeutix has begun enrolling the first subjects in a phase 2b clinical trial to evaluate the safety and efficacy of sustained-release travoprost, according to…

Valeant announces $2 billion Securities Repurchase Program

November 20, 2014
A new securities repurchase program that will allow Valeant Pharmaceuticals to make purchases up to $2 billion of its senior notes, common shares and other securities…
More News Headlines »
Therapeutic Refractive Surgery

One-Step Transepithelial Photorefractive Keratectomy With Mitomycin C as an Early Treatment for LASIK Flap Buttonhole Formation

Journal of Refractive Surgery
Online Advanced Release, November 11, 2014
To assess the efficacy and safety of early one-step transepithelial photorefractive keratectomy (PRK) with mitomycin C…
More »
CME
Sadda

In Focus: Advances in AMD – Managing Wet AMD in 2014 - What Do the Data Tell Us, and What Don’t They?

This activity is supported by an educational grant from Genentech, Inc.

A number of clinical trials have established the use of anti-VEGF therapy as first-line therapy in the management of…
More »
Meeting News Coverage Video
thumbnail for video 3900080232001

Surgeon gives pearls for dislocated IOLs

November 19, 2014
NEW YORK — At the OSN New York meeting here, Uday Devgan, MD, discusses pearls for properly diagnosing and…
More »
morganatic-roan
morganatic-roan